Treatment at first relapse in multiple myeloma: how to choose a drug?
The success story of indolent disease treatment expanded to difficult-to-treat patient groups
Promising uses for PET/CT and MRI in clinical practice
Making cancer treatments more affordable
Pros and cons of CML first-line therapy